Core Viewpoint - The announcement from Maogeping (01318.HK) regarding the planned share reduction by its major shareholders has attracted significant market attention, with a total of up to 17.2 million H-shares, representing 3.51% of the company's total issued shares, to be sold within six months [1][4]. Shareholder Reduction Plan - The shareholders involved in the reduction include Maogeping, his spouse Wang Liqun, and other family members, as well as a core executive, Song Hongquan [2]. - The reason for the share reduction is stated as personal financial needs, with proceeds intended for investments in the beauty industry and personal lifestyle improvements [3]. Market Reaction - Despite the announcement of the share reduction, Maogeping's stock price increased by 7.26% on January 7, closing at HKD 87.95, with a total market capitalization of HKD 431 billion [4]. Company Background - Maogeping has had a tumultuous journey in the capital markets, with multiple attempts to go public, including an A-share IPO application in 2016 and a successful listing on the Hong Kong Stock Exchange in December 2024 at an issue price of HKD 29.80 per share [5][6]. - The IPO was highly successful, with total subscription amounting to HKD 173.814 billion, making it the "frozen capital king" of 2024 [6]. Financial Performance - The company has shown robust financial growth, with total revenue increasing from CNY 1.577 billion in 2021 to CNY 2.886 billion in 2023, representing a compound annual growth rate (CAGR) of 35.3% [6]. - Net profit also grew from CNY 331 million in 2021 to CNY 664 million in 2023, with a CAGR of 41.6% [6]. - In its first year post-IPO (2024), the company achieved revenue of CNY 3.885 billion, a year-on-year increase of 34.6%, and a net profit of CNY 881 million, up 32.8% [6]. - For the first half of 2025, the company reported revenue of CNY 2.588 billion, a 31.3% increase year-on-year, and a net profit of CNY 670 million, growing by 36.1% [6].
上市刚满一年，毛戈平家族等拟套现13亿元“改善生活”